CRISPR Therapeutics AG (CRSP) — Analyst estimates
Consensus analyst estimates for CRISPR Therapeutics AG — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 17.50M | -1.21 | 5 |
| 2027 | 32.99M | -0.75 | 5 |
| 2028 | 537.34M | -2.57 | 9 |
| 2029 | 2.21B | 2.9 | 3 |
| 2030 | 5.50B | 15.4 | 3 |
Consensus analyst estimates by fiscal year.